San Ramon, California-based The Cooper Companies, Inc. (COO) is a global medical device company that develops and manufactures products for vision care, women's health, and fertility and surgical procedures. With a market capitalization of approximately $13.7 billion, the company operates through its two business units, CooperVision and CooperSurgical, serving healthcare professionals and patients in more than 130 countries while helping improve eye care and reproductive health outcomes worldwide.
COO is set to report its Q3 earnings soon. Ahead of the release, analysts expect the company to report diluted EPS of $1.11, up marginally from $1.10 in the year-ago quarter. However, COO has surpassed Wall Street's EPS estimates in each of the past four quarters, which is impressive.
